In today's Gold Coast Bulletin (page 2) is an article describing how "...researchers at Griffith University discovered a new cure" for human para-influenza virus (hPIV), which is the second biggest cause of acute respiratory tract infections in infants. The new treatment is the use of a new combination of drugs; Relenza and a drug called Suramin. It has been a very long time since I have seen Relenza's name in print, so must be positive; notwithstanding patent due to expire. Perhaps this is a "new indication" for the drug and we may get some patent extension! As a long term holder, I continue to dream this dog (Biota) will one day achieve the potential of those early days of the company.
BTA Price at posting:
57.0¢ Sentiment: Hold Disclosure: Held
HotCopper & The Market Online will be live From the Floor at the Mining News Select Conference and we want to bring the voice of our online audience to the show with us.
